Explore how emerging tech bio ventures are reshaping traditional market dynamics and capturing the attention of forward-thinking investors. This session dives into key trends in synthetic biology, computational life sciences, and platform-based drug discovery, highlighting strategies to accelerate breakthroughs and unlock value at scale. Hear seasoned venture experts discuss the evolving regulatory and investment landscapes, share approaches to building high-growth portfolios, and provide insights on nurturing disruptive companies from seed to maturity. Join a candid dialogue on how collaboration, cutting-edge research, and risk management converge to drive the future of tech bio innovation.